108P Pembrolizumab in pre-treated advanced non-small cell lung cancer (NSCLC) patients (pts): Impact of blood-based biomarkers on survival outcomes
- Resource Type
- Abstract
- Source
- In
Annals of Oncology September 2020 31 Supplement 4:S284-S284 - Subject
- Language
- ISSN
- 0923-7534